Phase Dashboard
Phase matters: early studies go quiet most often
The phase gradient shows that non-disclosure is not just sponsor-specific. Phase I is worst on rate, while the NA bucket dominates by scale.
Phase I rate
NA stock
Later phases
Eligible 2-year gap
Dashboard
The phase gradient shows that silence is not only sponsor-specific. It also varies along the development pathway itself.
How to read the dashboard
Interventional
441,191
All phase-labelled studies
Eligible older
249,507
2-year denominator
Phase I rate
76.7%
Highest phase-specific rate
NA stock
96,605
Largest unresolved block
Rates
Phase I is the quietest major phase on a rate basis, with early phase I and NA also notably opaque.
Rates show where missing results look routine within a phase rather than where the biggest raw backlog happens to sit.
Stock
The NA bucket overwhelms all later phases on raw unresolved stock because of its size.
The NA category matters because sheer volume can turn a middling or even moderate rate into the single largest public stock of unresolved studies.
Read Across Projects
Across The Series
Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.